Rare Cancers

The OptimUM-02 trial shows that the oral combination of darovasertib and crizotinib significantly improves outcomes for patients with a difficult-to-treat form of eye cancer, metastatic uveal melanoma that is HLA-A*02:01–negative. The treatment doubled median progression-free survival to 6.9 months compared to 3.1 months with standard therapies. It also reduced the risk of disease progression or […]

A population-based study using the Surveillance, Epidemiology, and End Results Program (SEER) database analyzed early mortality in patients with Angioimmunoblastic Tcell lymphoma (AITL) between 2000 and 2021. Researchers defined early mortality as death within 24 months of diagnosis. The results showed that AITL has a high risk of early death, with mortality reaching 38.5% within the first year and

A large multi-omics study of Angioimmunoblastic T-cell lymphoma (AITL) analyzed 174 patient cases and used patient-derived mouse models to better understand this aggressive blood cancer. Researchers found that the disease is driven mainly by genetic changes affecting epigenetic regulation, T-cell receptor signaling, and the PI3K/AKT pathway. The most frequent mutations included TET2 (81%), DNMT3A (31%), and

A new study examined whether Fingolimod, a drug originally approved to treat Multiple Sclerosis, could be repurposed to treat Adrenocortical Carcinoma. Researchers focused on the sphingolipid metabolic pathway and found that high activity of genes involved in producing Sphingosine1Phosphate (S1P) is linked to more advanced disease, more aggressive tumors, and poorer survival in patients with

A new study explored the anticancer effects of Celastrol, a bioactive compound from traditional Chinese medicine, against Adrenocortical Carcinoma using the H295R cancer cell line. Researchers found that Celastrol strongly reduced the survival of cancer cells in a dose-dependent manner, with an IC50 of about 1.63 µM. The compound mainly caused apoptosis, a form of

Primary vaginal cancer is rare (1%–2% of female genital tract cancers), strictly defined by the absence of prior/concurrent cervical or vulvar cancer. Increasing incidence in younger women is linked to HPV infection. The pathogenesis is largely HPV-dependent, progressing from HSIL to invasive cancer (2%−12% risk). Diagnosis requires biopsy and a thorough exam, typically after a patient presents

MRI-based radiomics is being studied for predicting 2-year recurrence in anal squamous cell carcinoma, marking a step forward in personalized treatment planning. By extracting quantitative features from medical images, radiomics goes beyond traditional visual interpretation to predict clinical outcomes. The integration of artificial intelligence (AI) enhances radiomic models, using machine learning to evaluate imaging data

Non-surgical treatment is increasingly effective for HPV-positive throat cancer, which responds well to radiation and chemotherapy. Avoiding surgery can reduce long-term side effects and improve quality of life for patients who are likely long-term survivors. Radiation therapy remains a cornerstone, with advances in de-escalated dosing that maintain effectiveness while minimizing debilitating side effects. Chemotherapy, alone